Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR)

Sponsor
Uppsala University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03966716
Collaborator
The Swedish Research Council (Other)
1,440
25
2
71.5
57.6
0.8

Study Details

Study Description

Brief Summary

A registerbased RCT will investigate whether arthroplasty can decrease the reoperation rate compared to internal fixation for patients with an undisplaced femoral neck fracture (Garden I-II).

Condition or Disease Intervention/Treatment Phase
  • Device: Arthroplasty
  • Device: Internal Fixation
N/A

Detailed Description

The aim of this study is to determine whether the treatment of elderly patients with an undisplaced femoral neck fracture (uFNF) can be improved by decreasing reoperation rates through replacing the hip instead of trying to preserve it. Patients ≥75 years with an uFNF will be included and randomized within the Swedish Fracture Register (SFR) platform to internal fixation (screws/pins) or arthroplasty (choice of hemi or total is at the surgeon's discretion). The primary outcome will be a composite variable that combines two variables (reoperations and mortality) into a single variable.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1440 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
HipSTHeR - a Registerbased Randomized Controlled Trial - Hip Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients.
Actual Study Start Date :
Sep 16, 2019
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arthroplasty

Arthroplasty, hemi or total depending on patient characteristics and surgeon's choice

Device: Arthroplasty
Patients with an undisplaced femoral neck fracture receive a hemi or total hip arthroplasty depending on each hospital's routine for patient age and mobility.

Active Comparator: Internal Fixation

Internal fixation with 2-3 screws or pins, or sliding hip screw device, depending on each hospital's routine

Device: Internal Fixation
Patients with an undisplaced femoral neck fracture undergo a closed reduction and internal fixation with 2-3 screws or pins, or sliding hip screw device. Type of fixation depends on each hospital's routine.

Outcome Measures

Primary Outcome Measures

  1. Composite variable comprising reoperation rate and mortality [1 to 2-year post-surgery]

    Both Death and mortality will be accounted for

Secondary Outcome Measures

  1. Reoperation rate [2-year post-surgery]

    Minor and major reoperations will be noted

  2. Long-term Mortality [2-year post-surgery]

    All deaths are recorded

  3. Short-term Mortality [30 day mortality]

    All deaths are recorded

  4. Patient reported outcome: SMFA [1-year post surgery]

    Short Musculoskeletal Functional Assessment (SMFA) questionnaire, will be routinely collected within the Swedish Fracture Register 1 year after the injury and compared with the results obtained by recall technique at the time of the fracture.

Other Outcome Measures

  1. Occurrence of adverse events. [1-year post-surgery]

    Adverse events, such as pulmonary embolism, infection, dislocation, myocardial infarction and stroke will be noted.

  2. Long-term reoperation rate [5 and 10 years post-surgery]

    Minor and major reoperations will be noted

  3. External validity [2-year post-surgery]

    Assessment of eligible patients not included in the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Undisplaced (Garden I-II) femoral neck fracture (within 72h)

  • treated at participating unit

  • informed consent

  • amenable for both treatment options

Exclusion Criteria:
  • no informed consent

  • pathological or stress fracture

  • peri-implant fracture

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uppsala University Hospital Uppsala Uppsala Lan Sweden 75185
2 Alingsås Hospital Alingsås Sweden
3 Borås Hospital Borås Sweden
4 Falu Hospital Falun Sweden
5 Sahlgrenska university Hospital Gothenburg Sweden
6 Gävle Hospital Gävle Sweden
7 Jönköping Hospital Jönköping Sweden
8 Kalmar Hospital Kalmar Sweden
9 Karlskrona Hospital Karlskrona Sweden
10 Kungälv Hospital Kungälv Sweden
11 Linköping University Hospital Linköping Sweden
12 Sunderby Hospital Luleå Sweden
13 Lycksele Hospital Lycksele Sweden
14 Skåne Universitetssjukhus Malmö Sweden
15 Mora Hospital Mora Sweden
16 Norrtälje Hospital Norrtälje Sweden
17 Nyköping Hospital Nyköping Sweden
18 Skellefteå Hospital Skellefteå Sweden
19 Skövde Hospital Skövde Sweden
20 Danderyd Hospital Stockholm Sweden
21 Stockholm South Hospital Stockholm Sweden
22 Trollhättan Hospital Trollhättan Sweden
23 Umeå University Hospital Umeå Sweden
24 Västervik Hospital Västervik Sweden
25 Västerås Hospital Västerås Sweden

Sponsors and Collaborators

  • Uppsala University
  • The Swedish Research Council

Investigators

  • Study Chair: Stergios Lazarinis, Uppsala University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Uppsala University
ClinicalTrials.gov Identifier:
NCT03966716
Other Study ID Numbers:
  • 2019-00140
First Posted:
May 29, 2019
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Uppsala University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2022